# Formoterol-beclomethasone in Patients With Bronchiectasis: a Randomized Controlled Trial

> **NCT03846570** · PHASE3 · TERMINATED · sponsor: **Erasmus Medical Center** · enrollment: 34 (actual)

## Conditions studied

- Bronchiectasis

## Interventions

- **DRUG:** Formoterol-beclomethasone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03846570
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-01-29
- **Primary completion:** 2022-07-05
- **Final completion:** 2022-07-05
- **Target enrollment:** 34 (ACTUAL)
- **Why stopped:** Insufficient inclusion rate (due to COVID-19 pandemic)
- **Last updated:** 2023-03-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03846570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03846570, "Formoterol-beclomethasone in Patients With Bronchiectasis: a Randomized Controlled Trial". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03846570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*